Intralesional 5 Fluorouracil For Basal Cell Carcinoma: A Case Review

Abstract

The most frequent of all non-melanoma skin cancer is basal cell carcinoma (BCC). In descending order of prevalence, the three most frequent BCC forms are nodular, superficial spreading, and penetrating variations. 15–26% of all cases of basal cell carcinoma (BCC) are superficial spreading basal cell carcinomas (SSBCC). However, it can also be noticed on the face. It typically affects the trunk and upper extremities. Excision surgery is the most widely utilized and gold standard treatment for BCC. Intralesional chemotherapeutic drug 5-fluorouracil (5-FU) may be used as adjuvants or alternatives. BCC has modest fatality rates, but because it is so common, it still poses a serious and expensive health burden.